Laura Rich focuses her practice on matters pertaining to the U.S. Food and Drug Administration (FDA), including food, cosmetic products, drugs, devices, and tobacco products. As a former senior policy advisor with the FDA and a seasoned attorney, Laura provides valuable perspective to clients who turn to her for advice on new state and federal requirements related to FDA-regulated products, how to respond to changes in regulatory policy, and providing input to FDA rulemakings. Laura's practice includes overall regulatory strategy and support, including for new dietary ingredient notifications (NDIN). Laura also focuses on government investigations, FDA enforcement actions, internal compliance, and other regulatory matters in the food and drug industry. Laura also served as a senior attorney at the U. S. Securities and Exchange Commission, where she worked to resolve, plan, and execute investigations and inspections of regulated entities.